Zhong W - Search Results

1

Design, synthesis and pharmacological evaluation of a novel mTOR-targeted anti-EV71 agent.

Hao T, Li Y, Fan S, Li W, Wang S, Li S, Cao R, Zhong W. Hao T, et al. Among authors: zhong w. Eur J Med Chem. 2019 Aug 1;175:172-186. doi: 10.1016/j.ejmech.2019.04.048. Epub 2019 Apr 24. Eur J Med Chem. 2019. PMID: 31082764

2

[Targeted AGEes and AGEs cross-link in drug discovery: preventing and reversing arterial sclerosis in aging and diabetes].

Zhong W, Wang LL, Cui H, Li S. Zhong W, et al. Yao Xue Xue Bao. 2005 Jan;40(1):91-6. Yao Xue Xue Bao. 2005. PMID: 15881334 Review. Chinese. No abstract available.

3

FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.

Zhao L, Huang W, Liu H, Wang L, Zhong W, Xiao J, Hu Y, Li S. Zhao L, et al. Among authors: zhong w. J Med Chem. 2006 Jul 13;49(14):4059-71. doi: 10.1021/jm0502384. J Med Chem. 2006. PMID: 16821768

4

1-Oxo-3-substitute-isothiochroman-4-carboxylic acid compounds: synthesis and biological activities of FAS inhibition.

Wang X, Zhao G, Chen Y, Xu X, Zhong W, Wang L, Li S. Wang X, et al. Among authors: zhong w. Bioorg Med Chem Lett. 2009 Feb 1;19(3):770-2. doi: 10.1016/j.bmcl.2008.12.010. Epub 2008 Dec 7. Bioorg Med Chem Lett. 2009. PMID: 19097781

5

Novel fatty acid synthase (FAS) inhibitors: design, synthesis, biological evaluation, and molecular docking studies.

Wang X, Lin J, Chen Y, Zhong W, Zhao G, Liu H, Li S, Wang L, Li S. Wang X, et al. Among authors: zhong w. Bioorg Med Chem. 2009 Mar 1;17(5):1898-904. doi: 10.1016/j.bmc.2009.01.050. Epub 2009 Jan 29. Bioorg Med Chem. 2009. PMID: 19223187

6

(S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl) propanoic acid compounds: synthesis and biological evaluation of dual PPARalpha/gamma agonists.

Zhou X, Chen W, Xu C, Fan S, Xie Y, Zhong W, Wang L, Li S. Zhou X, et al. Among authors: zhong w. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2605-8. doi: 10.1016/j.bmcl.2010.02.071. Epub 2010 Mar 1. Bioorg Med Chem Lett. 2010. PMID: 20299214

7

Synthesis of a series of novel 2,4,5-trisubstituted selenazole compounds as potential PLTP inhibitors.

Ling C, Zheng Z, Jiang XC, Zhong W, Li S. Ling C, et al. Among authors: zhong w. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5123-5. doi: 10.1016/j.bmcl.2010.07.017. Bioorg Med Chem Lett. 2010. PMID: 20667734

8

5-(4-Chloro-phen-yl)-1-(2,4-dichloro-phen-yl)-4-methyl-N-(3-pyridylmeth-yl)-1H-pyrazole-3-carboxamide.

He X, Zhong W, Xiao J, Zheng Z, Li S. He X, et al. Among authors: zhong w. Acta Crystallogr Sect E Struct Rep Online. 2009 Apr 18;65(Pt 5):o1077. doi: 10.1107/S1600536809013609. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21583892 Free PMC article.

9

(3S,4R,4aS,7aR,12bS)-3-Cyclo-propyl-meth-yl-4a,9-dihy-droxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octa-hydro-1H-4,12-methano-1-benzofuro[3,2-e]isoquinolin-3-ium 2,2,2-trifluoro-acetate methanol solvate.

Cai X, Zhou X, Zheng Z, Zhong W, Li S. Cai X, et al. Among authors: zhong w. Acta Crystallogr Sect E Struct Rep Online. 2010 Oct 20;66(Pt 11):o2868. doi: 10.1107/S1600536810041164. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21589050 Free PMC article.

10

Novel immunomodulators based on an oxazolin-2-one-4-carboxamide scaffold.

He X, Wang L, Zheng Z, Xiao J, Zhong W, Li S. He X, et al. Among authors: zhong w. Bioorg Med Chem Lett. 2012 Jan 1;22(1):553-7. doi: 10.1016/j.bmcl.2011.10.088. Epub 2011 Nov 6. Bioorg Med Chem Lett. 2012. PMID: 22119341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,838 results

Search Page

Filters